TP53 and breast cancer: Altogether, phytochemicals halt the progression of the cell cycle of BC cells by either inhibiting the expression and activity of cyclins (B1, D1, and E) and CDKs (4, 6, 7) or increasing the expression of CDKs inhibitors (p18, p21, p27, and p53).